Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

TubeClear System Evaluation in Pediatric Patients

NCT: NCT07570537 · NOT_YET_RECRUITING

NCT IDNCT07570537
StatusNOT_YET_RECRUITING
Start Date2026-06-01
Completion2028-06-01

Brief Summary

Enteral access devices (EADs) provide necessary hydration, nutrition, and medications to numerous patients in hospitals across the United States. When patient's EAD becomes clogged it can delay administration of important nutrition and medications which can cause adverse effects such as malnutrition, and dehydration, especially in pediatric patients. Traditional methods of unclogging EADs can require the use of special enzymes or chemicals but these produce a variable rate of success. The TubeClear system has been developed to help alleviate the need for use of special enzymes or chemicals and to provide a quick, safe alternative for those with a clogged or sluggish EAD all while at the patient's bedside. This system prevents the need for subsequent exposure to radiation and contrast media for confirmation of EAD location after replacement.

Frequently Asked Questions

What is TubeClear System Evaluation in Pediatric Patients?

TubeClear System Evaluation in Pediatric Patients is a clinical trial registered under NCT07570537. Current status: NOT_YET_RECRUITING.

What is the status of NCT07570537?

The current status of NCT07570537 (TubeClear System Evaluation in Pediatric Patients) is: NOT_YET_RECRUITING.

When did TubeClear System Evaluation in Pediatric Patients start?

TubeClear System Evaluation in Pediatric Patients started on 2026-06-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.